派林生物: 第十届董事会第十五次会议决议公告

Group 1 - The company held its 15th meeting of the 10th Board of Directors on May 30, 2025, via communication method, with all 13 directors present [1] - The Board discussed and approved a report regarding the rectification of issues pointed out in the administrative regulatory measures decision by the Shanxi Securities Regulatory Bureau, emphasizing compliance and internal control improvements [1][2] - The company aims to strictly adhere to relevant regulations, enhance operational awareness, and strengthen management of subsidiaries to protect the interests of the company and its shareholders [1]